Original Research

Concurrent apatinib and docetaxel vs apatinib monotherapy as third- or subsequent-line therapy for advanced gastric adenocarcinoma: a retrospective study

Lin H, Han D, Fu G, Liu C, Wang L, Han S, Liu B, Yu J

OncoTargets and Therapy 2019, 12:1681-1689

Published Date: 28 February 2019